rs75004775

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_014844.5(TECPR2):​c.3465C>A​(p.Ser1155Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000744 in 1,613,698 control chromosomes in the GnomAD database, including 18 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. S1155S) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00074 ( 4 hom., cov: 33)
Exomes 𝑓: 0.00074 ( 14 hom. )

Consequence

TECPR2
NM_014844.5 missense

Scores

2
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.856

Publications

3 publications found
Variant links:
Genes affected
TECPR2 (HGNC:19957): (tectonin beta-propeller repeat containing 2) The protein encoded by this gene is a member of the tectonin beta-propeller repeat-containing (TECPR) family, and contains both TECPR and tryptophan-aspartic acid repeat (WD repeat) domains. This gene has been implicated in autophagy, as reduced expression levels of this gene have been associated with impaired autophagy. Recessive mutations in this gene have been associated with a hereditary form of spastic paraparesis (HSP). HSP is characterized by progressive spasticity and paralysis of the legs. There is also some evidence linking mutations in this gene with birdshot chorioretinopathy (BSCR), which results in inflammation of the choroid and retina. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Aug 2015]
TECPR2 Gene-Disease associations (from GenCC):
  • hereditary spastic paraplegia 49
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0030600429).
BP6
Variant 14-102452452-C-A is Benign according to our data. Variant chr14-102452452-C-A is described in ClinVar as Benign. ClinVar VariationId is 473091.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000741 (113/152394) while in subpopulation EAS AF = 0.0179 (93/5184). AF 95% confidence interval is 0.015. There are 4 homozygotes in GnomAd4. There are 59 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TECPR2NM_014844.5 linkc.3465C>A p.Ser1155Arg missense_variant Exon 16 of 20 ENST00000359520.12 NP_055659.2 O15040-1
TECPR2NM_001172631.3 linkc.3465C>A p.Ser1155Arg missense_variant Exon 16 of 17 NP_001166102.1 O15040-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TECPR2ENST00000359520.12 linkc.3465C>A p.Ser1155Arg missense_variant Exon 16 of 20 1 NM_014844.5 ENSP00000352510.7 O15040-1
TECPR2ENST00000558678.1 linkc.3465C>A p.Ser1155Arg missense_variant Exon 16 of 17 1 ENSP00000453671.1 O15040-2

Frequencies

GnomAD3 genomes
AF:
0.000749
AC:
114
AN:
152276
Hom.:
4
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000131
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0179
Gnomad SAS
AF:
0.00310
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000441
Gnomad OTH
AF:
0.000478
GnomAD2 exomes
AF:
0.00158
AC:
391
AN:
248182
AF XY:
0.00159
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000290
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0174
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000180
Gnomad OTH exome
AF:
0.000493
GnomAD4 exome
AF:
0.000744
AC:
1087
AN:
1461304
Hom.:
14
Cov.:
33
AF XY:
0.000763
AC XY:
555
AN XY:
726948
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33476
American (AMR)
AF:
0.0000224
AC:
1
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26118
East Asian (EAS)
AF:
0.0210
AC:
834
AN:
39686
South Asian (SAS)
AF:
0.00219
AC:
189
AN:
86224
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53140
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0000135
AC:
15
AN:
1111820
Other (OTH)
AF:
0.000795
AC:
48
AN:
60366
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
71
142
213
284
355
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000741
AC:
113
AN:
152394
Hom.:
4
Cov.:
33
AF XY:
0.000792
AC XY:
59
AN XY:
74522
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41602
American (AMR)
AF:
0.000131
AC:
2
AN:
15314
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.0179
AC:
93
AN:
5184
South Asian (SAS)
AF:
0.00290
AC:
14
AN:
4830
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10632
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000441
AC:
3
AN:
68038
Other (OTH)
AF:
0.000473
AC:
1
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
5
11
16
22
27
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000151
Hom.:
0
Bravo
AF:
0.000895
ExAC
AF:
0.00161
AC:
195
Asia WGS
AF:
0.00520
AC:
18
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary spastic paraplegia 49 Benign:2
Jan 23, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Hereditary spastic paraplegia Benign:1
Jun 13, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.64
T
BayesDel_noAF
Benign
-0.68
CADD
Benign
0.14
DANN
Benign
0.97
DEOGEN2
Benign
0.10
T;.
Eigen
Benign
-1.4
Eigen_PC
Benign
-1.5
FATHMM_MKL
Benign
0.16
N
LIST_S2
Benign
0.77
T;T
MetaRNN
Benign
0.0031
T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.4
L;L
PhyloP100
-0.86
PrimateAI
Benign
0.36
T
PROVEAN
Benign
-1.3
N;N
REVEL
Benign
0.072
Sift
Uncertain
0.016
D;T
Sift4G
Uncertain
0.048
D;T
Polyphen
0.45
B;.
Vest4
0.41
MutPred
0.30
Gain of helix (P = 0.0325);Gain of helix (P = 0.0325);
MVP
0.068
MPC
0.37
ClinPred
0.018
T
GERP RS
-7.6
Varity_R
0.076
gMVP
0.16
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs75004775; hg19: chr14-102918789; API